Stay updated on Sitagliptin in GVHD Prevention Clinical Trial
Sign up to get notified when there's something new on the Sitagliptin in GVHD Prevention Clinical Trial page.

Latest updates to the Sitagliptin in GVHD Prevention Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe ClinicalTrials.gov page footer now displays software revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check19 days agoChange DetectedA sitewide NIH notice explains that federal agencies are transitioning to using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference0.7%

- Check26 days agoChange DetectedThe footer now displays website revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check33 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check53 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history and the previous revision v3.6.6 was removed from the visible history.SummaryDifference0.1%

- Check74 days agoChange DetectedA new revision entry 'v3.6.6' was added to the version history, replacing the previous 'v3.6.5' entry. This indicates a minor site release update reflected in the study record history.SummaryDifference0.1%

Stay in the know with updates to Sitagliptin in GVHD Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitagliptin in GVHD Prevention Clinical Trial page.